WILMINGTON, DE — Incyte (Nasdaq: INCY) announced it will present at three investor conferences in March, with live webcasts available on its investor relations website.
The company said it will participate in the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 10:30 a.m. EST.
Incyte is also scheduled to present at the Leerink Partners 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 9:20 a.m. EDT.
A third presentation is planned for the Barclays 28th Annual Global Healthcare Conference on Wednesday, March 11, 2026, at 8:30 a.m. EDT.
Live webcasts of the presentations will be available at Investor.Incyte.com and archived for replay for 30 days, according to the company.
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of therapies in oncology and inflammation and autoimmunity. The company is headquartered in Wilmington and operates in North America, Europe and Asia.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.
